Published in N Engl J Med on July 20, 1972
The granuloma in Crohn's disease. Gut (1979) 1.54
Dendritic cells and scavenger macrophages in chronic inflammatory bowel disease. Gut (1989) 1.29
Morphological and immunohistochemical findings in upper gastrointestinal biopsies of patients with Crohn's disease of the ileum and colon. J Clin Pathol (1982) 1.19
Excisional surgery with ileostomy for Crohn's colitis with particular reference to factors affecting recurrence. Gut (1974) 1.14
Proximal recurrence and the fate of the rectum following excisional surgery for Crohn's disease of the large bowel. Ann Surg (1981) 1.13
Intra-abdominal abscess in regional enteritis. Ann Surg (1991) 0.97
Ileorectal anastomosis in patients with Crohn's disease of the colon. Gut (1977) 0.82
Colorectal adenocarcinoma in Crohn's disease. Ann Surg (1996) 0.78
Stricture of the anorectum in Crohn's disease involving the colon. Ann Surg (1975) 0.78
Postoperative recurrence in Crohn's disease. The effect of the initial length of bowel resection and operative procedure. Ann Surg (1984) 0.78
Systematic review with meta-analysis: recurrence of Crohn's disease after total colectomy with permanent ileostomy. Aliment Pharmacol Ther (2016) 0.75
Rectal biopsy as a prognostic guide in Crohn's colitis. J Clin Pathol (1977) 0.75
Post-operative recurrence of Crohn's disease after definitive stoma: an underestimated risk. Int J Colorectal Dis (2016) 0.75
A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med (1997) 10.67
Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med (1994) 6.05
The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) (1976) 4.81
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut (2005) 3.86
Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease. Am J Gastroenterol (2000) 3.36
Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study. N Engl J Med (1980) 3.01
Carcinoma arising in anorectal fistulas of Crohn's disease. Dis Colon Rectum (1998) 2.70
6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity. Ann Intern Med (1989) 2.70
Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. Gastroenterology (1999) 2.62
Reoperation and recurrence in Crohn's colitis and ileocolitis Crude and cumulative rates. N Engl J Med (1975) 2.59
Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia. Gastroenterology (1992) 2.51
Perforating and non-perforating indications for repeated operations in Crohn's disease: evidence for two clinical forms. Gut (1988) 2.51
Studies in myasthenia gravis: effects of thymectomy. Results on 185 patients with nonthymomatous and thymomatous myasthenia gravis, 1941-1969. Am J Med (1971) 2.50
Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology (1979) 2.48
Colonoscopic polypectomy in chronic colitis: conservative management after endoscopic resection of dysplastic polyps. Gastroenterology (1999) 2.25
Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study. Am J Gastroenterol (2000) 2.14
Preliminary report: cyclosporin in treatment of severe active ulcerative colitis. Lancet (1990) 2.13
The long-term outcome of ulcerative colitis treated with 6-mercaptopurine. Am J Gastroenterol (1996) 1.83
A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer (1981) 1.83
Summary of a workshop on clindamycin colitis. J Infect Dis (1976) 1.78
How effective are current drugs for Crohn's disease? A meta-analysis. J Clin Gastroenterol (1992) 1.75
Response of the normal and pathological human gastric mucosa to an instilled acid load. Gastroenterology (1968) 1.59
An engineered human antibody to TNF (CDP571) for active Crohn's disease: a randomized double-blind placebo-controlled trial. Gastroenterology (2001) 1.57
Fecal alpha 1-antitrypsin measurement: an indicator of Crohn's disease activity. Gastroenterology (1985) 1.53
Crohn's disease and acute leukocytoclastic vasculitis of skin. Am J Gastroenterol (1996) 1.53
Cluster of inflammatory bowel disease in three close college friends? J Clin Gastroenterol (1993) 1.52
Imparied lymphocyte responsiveness in inflammatory bowel disease. Gastroenterology (1973) 1.51
Microgranulomas in grossly normal rectal mucosa in Crohn's disease. Am J Clin Pathol (1977) 1.51
Patterns of neoplasia in Crohn's disease and ulcerative colitis. Cancer (1980) 1.45
Cancer in Crohn's disease after diversionary surgery. A report of seven carcinomas occurring in excluded bowel. Am J Surg (1978) 1.44
Risk factors for postoperative recurrence of Crohn's disease. Gastroenterology (1983) 1.43
Short-term lymphocyte cultures in regional enteritis. Lancet (1970) 1.43
Perpetuation of published medical errors. Lancet (1993) 1.43
Granulomatous ileocolitis. Gut (1966) 1.42
ACTH-induced adrenal hemorrhage: a complication of therapy masquerading as an acute abdomen. J Clin Gastroenterol (1990) 1.40
Screening and surveillance colonoscopy in chronic Crohn's colitis. Gastroenterology (2001) 1.39
Experience with Eudragit-S-coated mesalamine (Asacol) in inflammatory bowel disease. An open study. J Clin Gastroenterol (1993) 1.38
Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis. Gut (1976) 1.38
Glucose therapy in short-bowel syndrome. Lancet (1971) 1.36
Cyclosporin for severe ulcerative colitis: a user's guide. Am J Gastroenterol (1997) 1.36
Extraintestinal cancers in inflammatory bowel disease. Cancer (1985) 1.34
Clinical course, late results, and pathological nature of inflammatory disease of the colon initially sparing the rectum. Gut (1967) 1.32
The therapeutic efficacy of 6-mercaptopurine in refractory ulcerative colitis. Am J Gastroenterol (1990) 1.29
Frequency of inflammatory bowel disease in offspring of couples both presenting with inflammatory bowel disease. Gastroenterology (1991) 1.27
Cutaneous vasculitis complicating coeliac disease. Gut (1981) 1.27
A histologic reappraisal of the thymus in myasthenia gravis. A correlative study of thymic pathology and response to thymectomy. Arch Pathol (1971) 1.27
Is there Kveim responsiveness in Crohn's disease? Lancet (1971) 1.26
Uveitis (iritis) associated with ulcerative and granulomatous colitis. Gastroenterology (1967) 1.23
Chronic portal-systemic encephalopathy after ileostomy and colonic resection. Lancet (1966) 1.22
Trauma and the pyoderma gangrenosum of inflammatory bowel disease. Gut (1981) 1.22
Activation of c-Ki-ras in human gastrointestinal dysplasias determined by direct sequencing of polymerase chain reaction products. Cancer Res (1990) 1.20
The role of leukopenia in the 6-mercaptopurine-induced remission of refractory Crohn's disease. Am J Gastroenterol (1994) 1.20
Granulomatous diseases of the gastrointestinal tract. Annu Rev Med (1966) 1.20
Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine. A prospective, randomized, placebo-controlled, double-blind, dose-ranging clinical trial. Gastroenterology (1987) 1.19
The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome. J Clin Gastroenterol (1984) 1.19
Obstructive hydronephrosis. A frequent but seldom recognized complication of granulomatous disease of the bowel. N Engl J Med (1969) 1.18
Tumor-associated (CEA-reacting) antigen in patients with inflammatory bowel disease. N Engl J Med (1972) 1.18
Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome. Gastroenterology (1981) 1.18
Neonatal hepatitis and biliary atresia associated with trisomy 17-18 syndrome. N Engl J Med (1969) 1.17
Granulomatous colitis--pathogenetic concepts. Gastroenterology (1966) 1.17
Occurrence of Clostridium difficile toxin during the course of inflammatory bowel disease. Gastroenterology (1981) 1.16
Inhibition by diphenylhydantoin of folic acid absorption in man. Gastroenterology (1972) 1.16
Mucosal-cell counts in ulcerative and granulomatous colitis. Am J Clin Pathol (1975) 1.15
Cerebrovascular occlusions in relatively young patients with regional enteritis. JAMA (1971) 1.12
Influence of glucagon on pancreatic exocrine secretion. Gastroenterology (1969) 1.12
Rectal biopsy in patients with Crohn's disease. Normal mucosa on sigmoidoscopic examination. JAMA (1977) 1.11
Secretion of calcium by the canine pancreas. Gastroenterology (1967) 1.10
Granulomas do not affect postoperative recurrence rates in Crohn's disease. Gastroenterology (1982) 1.10
Ulcerative and granulomatous colitis. J Mt Sinai Hosp N Y (1967) 1.09
Outcome of toxic dilatation in ulcerative and Crohn's colitis. J Clin Gastroenterol (1985) 1.07
T and B lymphocytes and cutaneous anergy in inflammatory bowel disease. Ann N Y Acad Sci (1976) 1.07
The role of sigmoidoscopy and rectal biopsy in diagnosis and management of inflammatory bowel disease: personal experience. Am J Gastroenterol (1988) 1.06
The amylase-creatinine clearance ratio. Diagnostic parameter or physiologic phenomenon? Am J Gastroenterol (1974) 1.06
Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease. Dig Dis Sci (1985) 1.05
Complications of Crohn's disease predisposing to dysplasia and cancer of the intestinal tract: considerations of a surveillance program. J Clin Gastroenterol (1984) 1.04
Mucosal blood flow in canine antral and fundic pouches. Gastroenterology (1971) 1.04
Proctitis after fecal diversion in Crohn's disease and its elimination with reanastomosis: implications for surgical management. Report of four cases. Gastroenterology (1984) 1.04
Infliximab therapy for ulcerative colitis: many unanswered questions. Am J Gastroenterol (2001) 1.04
Carcinoma of the intestinal tract in Crohn's disease: results of a survey conducted by the National Foundation for Ileitis and colitis. Am J Gastroenterol (1983) 1.04
Lymphoma in inflammatory bowel disease. Cancer (1992) 1.03
Effect of secretin and acetazolamide on the volume and electrolyte composition of hepatic bile in man. Gastroenterology (1969) 1.02
A history of immunosuppressive drugs in the treatment of inflammatory bowel disease: origins at the Mount Sinai Hospital. Mt Sinai J Med (1996) 1.02
Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease. Inflamm Bowel Dis (2001) 1.02
The course of inflammatory bowel disease during pregnancy and postpartum. Am J Gastroenterol (1981) 1.01
Inflammatory bowel disease and immune thrombocytopenic purpura: is there a correlation? Am J Gastroenterol (1997) 1.01
Malabsorption and metastatic melanoma. Mt Sinai J Med (1973) 1.01
Idiopathic retroperitoneal fibrosis and sclerosing cholangitis associated with a reticulum cell sarcoma. Report of a case. Gastroenterology (1972) 1.01
Amyloidosis and inflammatory bowel disease. A 50-year experience with 25 patients. Medicine (Baltimore) (1992) 1.01
Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamine. Mt Sinai J Med (2001) 1.01